Press Release

RepliCel Retains Christina Cameron as Canadian Investor Relations Consultant

10 years ago Jun 04, 2014

VANCOUVER, BC – June 5, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...

RepliCel Life Sciences Inc. Announces Closing of Second Tranche of Private Placement

10 years ago May 20, 2014

NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES ORDISSEMINATION IN OR INTO THE UNITED STATES...

RepliCel Life Sciences’ Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness

10 years ago May 19, 2014

VANCOUVER, BC – May 20, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

RepliCel Life Sciences Inc. Announces Closing of Brokered and Non-Brokered Private Placement

11 years ago May 08, 2014

NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES ORDISSEMINATION IN OR INTO THE UNITED STATES...

RepliCel Life Sciences Announces Brokered Private Placement

11 years ago Mar 27, 2014

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

RepliCel Reports 2013 Annual Financial Results

11 years ago Mar 17, 2014

VANCOUVER, BC – March 18, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

RepliCel Retains Ubika Communication for Online Capital Market Exposure

11 years ago Feb 25, 2014

VANCOUVER, BC – February 26, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...

RepliCel Receives Japanese Patent Covering its Hair Regeneration Technology

11 years ago Jan 12, 2014

VANCOUVER, BC – January 13, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...

RepliCel to Commence Trading on the TSX Venture Exchange

11 years ago Jan 08, 2014

VANCOUVER, BC – January 9, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CSE: RP)...

RepliCel Announces Conditional Approval from TSX Venture Exchange

11 years ago Jan 01, 2014

VANCOUVER, BC – January 2, 2014 –RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB:...

RepliCel Reports Progress on Shiseido Technology Transfer for RCH-01 Treatment for Pattern Baldness

11 years ago Dec 18, 2013

VANCOUVER, BC – December 19, 2013 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CNSX: RP)...

RepliCel Reports Third Quarter 2013 Financial Results and Provides Corporate Update

11 years ago Nov 19, 2013

VANCOUVER, BC – November 20, 2013 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CNSX: RP),...

RepliCel Forms Clinical Advisory Board to Support the Development of RCT-01 for the Treatment of Chronic Tendinosis

11 years ago Oct 29, 2013

VANCOUVER, BC – October 30, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...

RepliCel Announces Stock Option Grant

11 years ago Sep 05, 2013

VANCOUVER, BC – September 6, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...

RepliCel Retains Westwicke Partners as Investor Relations Counsel

11 years ago Sep 03, 2013

VANCOUVER, BC – September 4, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...

RepliCel Announces Closing of Private Placement

11 years ago Jul 18, 2013

VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness

11 years ago Jul 10, 2013

VANCOUVER, BC – July 11, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License

12 years ago May 28, 2013

Tokyo, Japan and Vancouver, Canada – May 29, 2013 – RepliCel Life Sciences Inc. (the...

RepliCel Announces Closing of Private Placement

12 years ago May 20, 2013

VANCOUVER, BC – May 21, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise

12 years ago Apr 29, 2013

VANCOUVER, BC – April 30, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.